Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study

R E Clifford; D Harji; L Poynter; R Jackson; R Adams; N S Fearnhead; D Vimalachandran; ReCaP Steering Committee and Collaborators

doi:10.1093/bjs/znab129

Rectal cancer management during the COVID-19 pandemic (ReCaP): multicentre prospective observational study

Br J Surg. 2021 Nov 11;108(11):1270-1273. doi: 10.1093/bjs/znab129.

Authors

R E Clifford¹, D Harji², L Poynter³, R Jackson⁴, R Adams⁵, N S Fearnhead⁶, D Vimalachandran^{1

7}; ReCaP Steering Committee and Collaborators

Collaborators

ReCaP Steering Committee and Collaborators:
A Vallance, M Evans, H Mohan, N Foley, E O'Connell, J Kinross, A Bhangu, A Acheson, S Moug, J Hughes, K Kong, M Fok, J Wilson, J D Jayasinghe, A Minicozzi, M A Thaha, H Patel, D Smith, M Martinez-Iglesias, S Argyropoulos, J Johnston, A Dosis, F Mosley, R Antakia, I Abu-Nayla, H Joshi, D Westwood, K Dixon, M Al-Azzawi, E Howie, D Watt, A Khan, K Ahmed, W Rea, P Nastro, S Williams, N Solanki, G Akritidis, C Bruce, L Dickerson, S Tewari, G Tewari, V Gupta, N Reay-Jones, J Sagar, S Kudchadkar, N Cirocchi, A Rai, O Al Habsha, S Duff, L Poynter, M Boshnaq, S Saeed, C J Wright, R Dickson-Lowe, M Evans, R Harries, N Spencer, K Parkins, V Bevan, S Bodla, A Ghafar, N Yassin, S Mills, J Law, J Lim, J Sarveswaran, S Dasmohapatra, D Worku, S J Moug, G Kourounis, A Alasadi, S Barman, N Battersby, S Ingram, D Arora, J Lund, P Daliya, M Elzawahry, S Abdul-Hamid, L Weenink, F D McDermott, I R Daniels, N J Smart, E T Walker, S J Muse, R Mirnezami, S Chowdhury, J Gilliland, G Williams, H Jones, H Whewell, D Harji, B Griffiths, A Farquharson, R Mashar, C Weerasinghe, M Ransome, M A Javed, A Samad, S Shamim, E Vitovska, C Hall, C Renfigo, I Maitra, J Norman, C Florance, Y El-Dhuwaib, R Clifford, D Vimalachandran, N Manu, S Kumar, K Altaf, S Ahmed, J Wyatt, M Mesri, J Alberts, N Keeling, A Mishra, N Ward, M Lim, L MacDonald, H S Elshafey, W Awad

Affiliations

¹ Institute of Cancer Medicine, University of Liverpool, Liverpool, UK.
² Population Health Science, Newcastle University, Newcastle upon Tyne, UK.
³ Imperial College London, London, UK.
⁴ Liverpool Clinical Trials Unit, Liverpool, UK.
⁵ University of Cardiff, Cardiff, UK.
⁶ Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
⁷ The Countess of Chester Hospital NHS Foundation Trust, Chester, UK.

Abstract

Concerns over unacceptable high mortality in patients with rectal cancer undergoing surgery or systemic therapy who contract COVID-19 have led to widespread adoption of alternative treatment strategies.The ReCaP study aimed to study these variations and associated outcomes.

Publication types

Multicenter Study
Observational Study

MeSH terms

Aged
Aged, 80 and over
COVID-19*
Female
Humans
Male
Middle Aged
Neoadjuvant Therapy / statistics & numerical data
Pandemics*
Prospective Studies
Quarantine*
Rectal Neoplasms / epidemiology
Rectal Neoplasms / therapy*
Time-to-Treatment*

Grants and funding

25350/CRUK_/Cancer Research UK/United Kingdom